Latest news, updates, and announcements from Neusignal Therapeutics.
Neusignal Therapeutics raises $34.5M Series B for Alzheimer's drug development Neusignal Therapeutics, a Tohoku University spinout developing a disease-modifying small-molecule drug for Alzheimer's-ty...
